News

AbbVie, Illinois and Manufacturing Plant

AbbVie to build API plant in Illinois as it steps up US production
The expansion is part of AbbVie’s larger $10 billion commitment to U.S. investment in the face of Trump’s tariff threats.
AbbVie to Invest $195M in New Illinois Manufacturing Plant
AbbVie is investing $195 million to build a new north Chicago manufacturing plant to expand its active pharmaceutical ingredient production in the U.S. The investment is part of the biopharmaceutical company's intention to spend $10 billion to expand innovation and manufacturing in the U.S.
AbbVie plans $195M API plant in Illinois as part of US investment campaign
As pharma companies big and small play up their U.S. investment plans during the second Trump administration, the particulars of one project at AbbVie are coming into focus. | As pharmas play up their U.
AbbVie expands North Chicago API production with $195m investment
AbbVie is investing $195m to strengthen domestic active pharmaceutical ingredient (API) production within the US, with the expansion of its manufacturing plant in North Chicago, Illinois. This development is part of a larger commitment by the company to invest more than $10bn in US capital for innovation and critical manufacturing capacity enhancement.
AbbVie to invest $195M to build plant in Illinois
AbbVie (NYSE:ABBV) has revealed plans to invest $195M in its manufacturing facility located in North Chicago, Illinois, to boost the production of active pharmaceutical ingredients domestically within the US.
Illinois secures AbbVie’s $195 million investment for North Chicago facility
AbbVie, the maker of Botox, Humira, and Rinvoq, will invest $195 million to expand its North Chicago manufacturing facility, creating at least 50 new jobs within the next three years.
AbbVie announces $195M investment to expand API manufacturing in U.S.
AbbVie (ABBV) announced a $195M investment in its North Chicago, Illinois manufacturing plant to expand domestic active pharmaceutical ingredient

AbbVie to invest $195 million in North Chicago facility that will produce active pharmaceutical ingredients

Construction on the site will begin in the fall and is expected to be finished by 2027. North Chicago is already home to ...
WICS4d

AbbVie to invest $195 million in expanding Illinois facility

Governor JB Pritzker, AbbVie, and the Illinois Department of Commerce and Economic Opportunity (DCEO) have announced a ...
Contract Pharma2d

AbbVie to Invest $195M in Chicago Manufacturing Plant

AbbVie will invest $195 million in its North Chicago, Illinois, manufacturing plant to expand domestic API production in the ...
The American Bazaar3d

AbbVie to invest $195 million in US drug ingredient manufacturing

AbbVie will invest $195M to expand API manufacturing at its North Chicago plant, boosting U.S. pharmaceutical innovation, ...
Business Facilities3d

$195M AbbVie Expansion Boosts Illinois Pharma Industry

The global biopharma firm will build a new API production facility near its global headquarters in North Chicago.
RiverBender.com4d

Pritzker Announces $195 Million Investment From AbbVie To Expand Footprint In Illinois

NORTH CHICAGO Governor JB Pritzker, AbbVie, and the Illinois Department of Commerce and Economic Opportunity (DCEO) today ...